Key takeaway
What This Development Means
Israel is consulting on concentration and use limits for micron-sized silver in five cosmetics product groups until 24 August 2026 at 10:56 Israel time. The draft creates no current Israeli duty or application date.
Do The Proposed Percentages Apply To Every Silver Ingredient In Cosmetics?
No. The consultation concerns micron-sized silver under the draft annex wording. Companies should verify substance identity, form, specifications and product category rather than applying the limits automatically to silver salts, nanomaterials or every silver-containing raw material.
Can Existing Israeli Stock Remain On Sale If The Notice Is Adopted?
The draft does not establish a stock or sell-through provision. Any transition will depend on the completed final notice and its commencement terms. Businesses should identify inventory now but avoid assuming either immediate withdrawal or automatic continued sale.
Source basis: Israeli Government Legislation Portal, micron silver cosmetics consultation (10 August 2026)
Israel's micron silver cosmetics consultation proposes concentration and use limits across five product groups, with comments open until 24 August 2026 at 10:56 Israel time. The Ministry of Health posted the draft pharmacists' notice on 10 August, giving manufacturers, importers, formulators, ingredient suppliers, laboratories and retailers a short window to assess Israeli portfolios and evidence.
What The Israel Micron Silver Cosmetics Consultation Proposes
The draft would update Israel's cosmetics annexes for micron-sized silver. It proposes maximum concentrations of 0.2% in rinse-off products, 0.3% in leave-on skin products, 0.2% in oral-hygiene products, 0.3% in nail products and 0.05% in children's mouthwash.
It would also update Annex IV colour-use conditions for micron silver. Businesses should read the official draft for the substance description and conditions rather than applying the percentages to every form of silver and its compounds, silver salt, nanomaterial or silver-containing ingredient.
This is a consultation, not an adopted restriction. The draft contains blank placeholders for the corresponding European Union measure, so those fields should not be filled by assumption. No Israeli application or sell-through date has yet been set.
Why The European Union Reference Needs Clarification
Israel is consulting under the European Union annex-update mechanism in section 55A12IZ of the Pharmacists Ordinance (New Version), 1981. The consultation page refers to subsection (h), while the draft Pharmacists' Notice invokes subsection (j). The draft also points to a 1 May 2026 European Union application date but leaves the regulation number, adoption date and Official Journal citation blank.
Commission Regulation (EU) 2026/78 is final and applies in the European Union from 1 May 2026. However, its published silver permissions do not align cleanly with the five concentration categories described in the Israeli consultation. Businesses therefore should not state that Israel is implementing Regulation 2026/78 or import the European Union's particle-size definitions into Israeli law.
Analysis: The drafting discrepancy is professionally significant. Businesses may be able to reuse formulation, specification and safety evidence, but they need an Israel-specific comparison and should seek clarification before the deadline because the final legal reference, limits, commencement, Hebrew wording and any transitional treatment remain unresolved.
Which Products And Operators Should Be Checked
Portfolio owners should search ingredient and raw-material records for silver, then distinguish micron-sized silver from other forms using supplier specifications, particle-characterisation evidence and intended function. The five named product groups need concentration checks against the proposed maxima.
Responsible persons and importers should also identify finished goods in development, production, transit and Israeli inventory. The draft does not provide a stock or sell-through rule, so companies should not promise continued sale of existing stock after an unknown future application date.
What Organisations Should Do By 24 August
Map affected formulations, confirm analytical and supplier evidence, and document where the proposed limits would require reformulation, relabelling or market withdrawal. Submit comments through the consultation portal before 10:56 Israel time on 24 August, focusing on technical feasibility, scope wording, commencement and transition evidence.
After the deadline, monitor the consultation page and Ministry of Health publications for a final Director's notice. Do not implement the proposal as a binding Israeli limit unless and until that notice is published. Continue to follow current cosmetics requirements.
Related Articles
China Cosmetics Registration Reform Cuts Dossier Burdens
China’s Announcement No. 70 immediately simplifies cosmetics and toothpaste registration while keeping safety accountability with businesses. Brands should redesign dossier workflows, strengthen supplier evidence retention, reassess animal-testing exemptions and validate data-reuse conditions. Existing products also need controlled updates when raw material manufacturers or specifications change after the reform takes effect.
California Targets Triphenyl Phosphate In Nail Products Under Safer Consumer Products Programme
California has added nail products containing TPhP above 250 ppm to its Priority Products List, triggering SCP notifications and safer-alternative review duties.
SCCS Prostaglandin Analogues Opinion Finds Lash Growth Ingredients Unsafe
SCCS prostaglandin analogues opinion finds lash serum ingredients unsafe due to reproductive toxicity concerns.
